Navigation Links
What green algae are up to in the dark
Date:2/14/2013

How green algae produce hydrogen in the dark is reported by biologists at the Ruhr-Universitt Bochum in the "Journal of Biological Chemistry". Hereby, they have uncovered a mechanism for the production of the gas which has hardly been examined before; usually, researchers are interested in light-driven hydrogen synthesis. "Hydrogen could help us out of the energy crisis", says Prof. Dr. Thomas Happe, head of the working group Photobiotechnology. "If you want to make green algae produce more hydrogen, it is important to understand all the production pathways."

Green algae produce hydrogen under stress - even in the dark

Single-celled green algae of the type Chlamydomonas are microscopically small organisms: ten of them fit side by side on a human hair. In some ways, microalgae are not so very different from higher plants, such as trees. For example, they also perform photosynthesis. Unlike land plants, they can use light energy for the production of molecular hydrogen (H2). "However, Chlamydomonas and co only form hydrogen under stress", says Thomas Happe. "The disposal of the energy-rich gas serves as a kind of overflow valve so that excess light energy does not damage the sensitive photosynthetic apparatus." Chlamydomonas can also produce hydrogen in the dark. Although this fact has been known for decades, H2 synthesis in the absence of light has barely been studied because much less of the gas is produced in the dark than in the light. Moreover, it is complicated to isolate large quantities of the key enzyme of the dark-reaction, the so-called pyruvate:ferredoxin oxidoreductase. The RUB researchers nevertheless tackled the project.

Hydrogen production in the dark mimicked in vitro

Happe's team reconstructed the core of the dark hydrogen production in vitro, thus demonstrating the underlying mechanism. In order to get to the proteins involved, the researchers had these produced by
'/>"/>

Contact: Prof. Dr. Thomas Happe
thomas.happe@rub.de
49-234-322-7026
Ruhr-University Bochum
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cities can reduce greenhouse gas emissions by 70 percent, says U of T researcher
2. New guide will allow electric utilities to develop Green Button Web tools
3. Aarhus University builds research station in North Greenland
4. In beef production, cow-calf phase contributes most greenhouse gases
5. Analysis of Greenland ice cores adds to historical record and provide glimpse into climates future
6. Toward reducing the greenhouse gas emissions of the Internet and telecommunications
7. Ancient red dye powers new green battery
8. Rice cultivates green batteries from plant
9. Fire and ice: Wildfires darkening Greenland snowpack, increasing melting
10. Greenphire CEO Sam Whitaker speaks on Sunshine Act and Clinical Trial Payments
11. An energy conscious workforce: New research looks at how to encourage staff to go green
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Wash. , Nov. 20, 2014 C-Labs ... for the Internet of Things (IoT), today announced the ... of chief operating officer. Previously a strategic advisor to ... finance, and operations. Mr. Traynor is based out of ... . He reports to Chris Muench , Chief ...
(Date:11/18/2014)... NEW YORK , Nov. 18, 2014 /PRNewswire/ ... iris-based identity authentication solutions, and MorphoTrust USA ... solutions and services, today announced a strategic partnership ... across enterprise, motor vehicle administration (MVA), airport screening ... leader in identity-related solutions, MorphoTrust serves consumers through ...
(Date:11/7/2014)... led by Dr. Debra Auguste, associate professor, biomedical ... The City College of New York, have identified ... for one of the most aggressive forms of ... have a high mortality rate owing to aggressive ... therapeutic options. However, Professor Auguste,s team, discovered the ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... training video produced by Rafael Ortega, MD, the vice-chair ... Boston Medical Center (BMC) and professor of anesthesiology at ... is featured in this week,s New England Journal ... is the fifth BMC-produced video to appear in the ...
... After 30 years with Chip Supply, Inc., President ... Perrott served in various capacities through the ... tenure, Chip Supply grew into the largest independent die ... global provider of high reliability interconnect solutions, serving the ...
... BUFFALO, NY -- Exposure to air pollution early in life ... may alter her DNA and may be associated with premenopausal ... Buffalo have shown. The findings indicated that higher air ... increase levels of E-cadherin, a protein important to the adhesion ...
Cached Biology News:Pulse oximetry training video by BMC anesthesiologist published in NEJM 2Air pollution exposure affects chances of developing premenopausal breast cancer 2
(Date:12/17/2014)... IN (PRWEB) December 17, 2014 ... Laboratory Excellence following its most recent COLA inspection. ... by COLA, a national healthcare accreditation organization. Accreditation ... standards of quality in day-to-day operations, demonstrate continued ... pass a rigorous on-site laboratory survey. ...
(Date:12/17/2014)... , Dec. 17, 2014  United Therapeutics Corporation ... executive promotions as well as changes to Martine ... Executive Promotions United Therapeutics announced the ... and Co-Chief Executive Officer and David Zaccardelli , ... In connection with these promotions, Dr. Rothblatt,s title will ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce that ... with PVM technology , is now available. The ... tool continuously captures high-resolution images under a wide ... prepares a report pairing the most relevant images ... This compelling blend of high resolution images and ...
(Date:12/15/2014)... BEIJING , Dec. 15, 2014  Origin Agritech Limited ... "), a technology-focused supplier of crop seeds in ... results for its fiscal year 2014 ended September 30, 2014, ... The Company will host a teleconference on January 8, ... Beijing time to discuss the results. To participate ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 2Origin Agritech Limited to Announce Fiscal 2014 Annual Financial Results on January 8th, 2015 3
... 18 Martek Biosciences,(Nasdaq: MATK ) announced today ... patented, vegetarian form of DHA omega-3 for brain, eye,and ... vegetarian DHA,Oroweat 9 Grain Bread with life,sDHA from Bimbo ... Pacific Northwest, California, Arizona,and Nevada., "This new launch ...
... Baxter,International Inc. (NYSE: BAX ) announced today ... an additional $2 billion of the company,s,common stock to ... authorization., Baxter has less than $700 million of ... that was authorized in March,2007. Shares will be repurchased ...
... Calif., March 18 TorreyPines Therapeutics,Inc. (Nasdaq: ... Phase II study of,NGX267, a muscarinic agonist in ... syndrome., The company is conducting a randomized, ... to evaluate,the safety, tolerability and efficacy of this ...
Cached Biology Technology:Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 2Martek Announces Launch of Oroweat 9 Grain Bread, First Bread with Martek's life'sDHA 3Baxter's Board of Directors Approves New Share Repurchase Authorization of $2 Billion 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 2TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 3TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia 4
Tube-O-DIALYZER Floats, small....
Nestin, Human...
Rabbit polyclonal to Survivin DEx3 ( Abpromise for all tested applications). entrezGeneID: 332 SwissProtID: O15392...
Smac/DIABLO (mouse) (CT) rabbit polyclonal antibody...
Biology Products: